2-cyclopropylquinazolin-4(3H)-one, 95.0%, 2.5g

(2-((2,5-Dichloropyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide, 95.0%, 1g

1,5-Dibromoanthraquinone>93.0%(HPLC)1g

methyl 5-methyl-7-oxo-4H,7H-thieno[3,2-b]pyridine-3-carboxylate, 1g

3,4-Dihydroxybenzaldehyde, 99.0%, 100g

Methyl-piperidin-3-ylmethyl-carbamic acid tert-butyl ester, 95.0%, 5g

(R)-1-(Furan-2-yl)ethanol, 95.0%, 250mg

Propargyl-PEG7-alcohol, 1g

Ultrasonic device series D, 11.5 l, D 130 1 piece

N-(3,5-dimethoxyphenyl)guanidine, 95.0%, 500mg

tert-butyl ((S)-1-((2S,4R)-4-((tert-butyldiphenylsilyl)oxy)-2-(((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)carbamoyl)pyrrolidin-1-yl)-1-oxonon-8-en-2-yl)carbamate, 98%, 50mg

1-(tert-Butyl) 3-ethyl (3R,4S)-4-aminopiperidine-1,3-dicarboxylate, 98%, 250mg

3-[4-(trifluoromethoxy)benzenesulfonamido]propanoic acid, 97%, 250mg